UroGen Support

Here to help patients get access to JELMYTO

We know getting patients access to JELMYTO is a crucial step in their treatment. To make this process as simple as possible, UroGen Support provides:

  • Comprehensive access and reimbursement support
    • Benefits investigations
    • Prior authorization and coverage appeal process assistance
    • Billing and coding assistance
    • Patient affordability and financial assistance for eligible patients. Additional restrictions and limitations may apply
  • Product acquisition and preparation coordination

UroGen Support

Need help? Contact us.

1-855-JELMYTO (1-855-535-6986)

Monday-Friday, 8 AM–8 PM ET

Overview of key steps

STEP
1

Provider enrolls patient in UroGen Support Program for JELMYTO

STEP
2

UroGen Support conducts benefits investigation, identifies potential prior authorization requirements, and determines eligibility for financial support options

STEP
4

JELMYTO is administered to the patient

STEP
3

UroGen Support and provider coordinate product acquisition, preparation, and delivery

STEP
4

JELMYTO is administered to the patient

Get started now

preview of patient enrollment form

Enrollment Form

This enrollment form must be completed and signed by the prescriber and patient and emailed or faxed to UroGen Support at Contact@UroGenSupport.com or 833-664-7216 in order for UroGen Support to provide assistance.Download iconDownload

Download Coding & Billing Guide

Billing and Coding Guide

This resource includes necessary billing and coding information for JELMYTO processing and reimbursement.Download iconDownload

Download Coding & Billing Guide

Billing and Coding Guide

This resource includes necessary billing and coding information for JELMYTO processing and reimbursement.Download iconDownload

Download Affordability Brochure

Affordability Brochure

UroGen Support is committed to helping patients get access to JELMYTO. This resource outlines the financial assistance programs that are available for eligible patients who have been prescribed JELMYTO. The appropriate program will depend on the patient's coverage.Download iconDownload


Additional resources

preview of declaration letter

Declaration Letter

Download iconDownload

PA and Appeals Checklist

PA and Appeals Checklist

Download iconDownload

PA and Appeals Checklist

PA and Appeals Checklist

Download iconDownload

Program Overview Brochure

Program Overview Brochure

Download iconDownload


preview of claim submission checklist

Claims Submission Checklist

Download iconDownload

Letter of Medical Necessity

Letter of Medical Necessity

Download iconDownload

Letter of Medical Necessity

Letter of Medical Necessity

Download iconDownload

Appeals Letter

Appeals Letter

Download iconDownload


JELMYTO Formulary Kit

JELMYTO Formulary Kit

Download iconDownload

JELMYTO J Code Brochure

JELMYTO J Code Brochure

Download iconDownload


You are encouraged to report negative side effects of prescription drugs to the FDA. Visit http://www.fda.gov/medwatch or call 1-800-FDA-1088. You may also report side effects to UroGen Pharma at 1-855-987-6436.

Please click here for JELMYTO Full Prescribing Information, including the Patient Information, for additional information.

Please click here for Full Prescribing Information, Instructions for Pharmacy and Instructions for Administration.